STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
about
The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapesIdentifying and targeting tumor-initiating cells in the treatment of breast cancerHER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signalingCisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cellsSTAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia.G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancerMetalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancerCD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.Breast cancer stem cells: are we ready to go from bench to bedside?miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma.Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.Cell lineage determinants as regulators of breast cancer metastasis.Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer.Overview of Cancer Stem Cells and Stemness for Community Oncologists.Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes.CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma.Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol.Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer.Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer.STAT3, stem cells, cancer stem cells and p63.Cancer Stem Cells are Regulated by STAT3 Signalling in Wilms Tumour.Mammary Stem Cells and Breast Cancer Stem Cells: Molecular Connections and Clinical ImplicationsBreast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
P2860
Q26799993-4F6BDB3E-A8DD-4BFF-9F8F-560B0612493AQ26851827-C76395EC-56EB-40F7-82F1-374C8E08D11EQ33737278-04961CB1-E48F-4340-9E9C-8B4F6482ECB5Q34227685-74D4C523-F339-4DED-BE18-72AB5F7ED348Q35176432-3DB0B14C-1423-4FE5-B6D7-3D4810A7C715Q35405293-046C2241-0212-46CA-BC0C-504BA64974B8Q35683077-24D54216-DC0B-4EE4-8A04-8EDC3085F79FQ35752008-A6D85BDA-F656-41FA-9CDF-28A879FC5A36Q36022273-CC0341E4-5516-416E-B642-68728821B4EBQ37129279-8DA3D90F-B50C-4A68-9895-342E2F879423Q37620891-BD1BB003-B28F-41BE-80AF-327504CA4E32Q37688297-A879633C-42AE-477F-BFA0-FE09FC68E401Q38696803-9686095C-B6FC-40AB-AFED-A09E346A6A3DQ38835514-DB7A300A-B133-48F8-A6A2-8F3E773AB052Q38902610-68053D57-BC0D-434D-B284-E8E1668DA70EQ38931701-FBCFDF90-F0A6-4C13-8056-7F86EDED59CFQ39014552-BB309278-1200-478F-8B90-50D294DB9885Q39088864-93BD6DC4-8F2C-441C-9D2D-69055A7CE2AAQ39406329-68CF83D8-FF9D-46C9-98B3-7DDC9324C20EQ41127816-AF41F12D-E3B7-4279-B042-18BFE9AD771AQ41714751-180F6B54-A804-4C4F-A2D3-04D79DEEDD12Q42289005-D9013380-9A82-4E66-852C-71A418F0D4ABQ42406267-C402F5DB-1271-48F4-BCB7-ED5282F0AE9CQ47146042-7FDFF2EF-F4A5-4427-BEBA-F03EBDB82D22Q48551091-591D3DF1-E689-4F28-A4E2-0700A58B3A79Q49544395-A520D5F6-FEAF-480C-9FFC-18D6BB8B156BQ52339863-85892910-7AF5-4CFE-A777-A274F64DFC2CQ55254109-EC9D3A99-571E-4E00-98C4-21E765F75B2EQ57112976-0EAFF458-A0F0-45E6-BD24-72DB37963562Q58555555-BCE03F68-6EFA-4703-9558-34B4D68391DC
P2860
STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
STAT3 signaling is activated p ...... models of human breast cancer.
@en
type
label
STAT3 signaling is activated p ...... models of human breast cancer.
@en
prefLabel
STAT3 signaling is activated p ...... models of human breast cancer.
@en
P2093
P2860
P356
P1433
P1476
STAT3 signaling is activated p ...... models of human breast cancer.
@en
P2093
David J Tweardy
Ivana Petrovic
Jeffrey M Rosen
John Landua
Kevin Roarty
Michael T Lewis
Susan G Hilsenbeck
P2860
P304
P356
10.1002/STEM.1752
P577
2014-10-01T00:00:00Z